Sveriges Riksbank
| Bid date, 2021-03-04 | |
| Bid Date | 2021-03-04 |
| Bid times | 14.00-14.30 (CET/CEST) on the Bid date |
| Offerent Amount | USD 10 billion |
| Maximum Permitted Volume of Bids | USD 4 billion from an individual institution |
| Settlement Date | 2021-03-08 |
| Minimum Permitted Bid Volume | 100 USD million per bid |
| Maximum Allocation | 40 per cent of the Offerend amount |
| Allocation time | Not later than 15.00 (CET/CEST) on the Bid date |
| Maturity Date | 2021-05-28 |
| Maximum Number of Bids | 10 per individual institution |
| Lowest Interest Supplement | 0.25 percentage points |
| Confirmation of bids to e-mail | eol@riksbank.se |
Stockholm, 2021-03-02
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alkane Resources Limited19.12.2025 01:33:33 CET | Press release
Alkane Doubles the Tested Depth Extent of the Storheden Deposit at Björkdal
eGain Corporation18.12.2025 22:48:21 CET | Press release
Achmea Selects eGain AI Knowledge Hub and AI Agent to Power Digital Transformation
Parker University18.12.2025 22:27:59 CET | Press release
Parker Seminars Announces Las Vegas 2026 (Feb. 26–28): The World’s Largest Chiropractic & Healthcare Event Celebrates 75 Years
Galapagos NV18.12.2025 22:01:00 CET | Press release
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
Bavarian Nordic A/S18.12.2025 20:41:21 CET | Pressemeddelelse
Bavarian Nordic iværksætter nyt langsigtet incitamentsprogram for koncernledelsen og udvalgte medarbejdere
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
